SPOTLIGHT: J&J's risky infringement defense flops


Here's a new infringement-suit tactic: say your product isn't as safe as your opponent's, so it falls outside the patent's safety profile. That's what Johnson & Johnson said in its defense against Boston Scientific claims of stent-related poaching. It didn't work. The judge said that the infringement ruling stands. Report